Patents by Inventor Christopher A. O'Brien

Christopher A. O'Brien has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12027676
    Abstract: An enclosed electrical device such as a battery pack for an electric powertrain system includes an enclosure having a tray and cover. The tray and cover together define an enclosure cavity. A radio frequency (RF) receiving node is located within the cavity. Printed circuit board assemblies (PCBAs) include an RF transmitting node. The PCBAs(s) are spaced apart from one another within the cavity. An RF shield guide layer is positioned between the PCBAs and the cover, such that the RF shield guide layer covers the PCBAs without covering the RF transmitting node. A battery pack and an electric powertrain system include the RF shield guide layer.
    Type: Grant
    Filed: December 10, 2021
    Date of Patent: July 2, 2024
    Assignee: GM Global Technology Operations LLC
    Inventors: Fiona E. Meyer-Teruel, Aseim M. Elfrgani, Christopher A. O'Brien, Sony Mathews, Hatem Elgothamy
  • Publication number: 20230187712
    Abstract: An enclosed electrical device such as a battery pack for an electric powertrain system includes an enclosure having a tray and cover. The tray and cover together define an enclosure cavity. A radio frequency (RF) receiving node is located within the cavity. Printed circuit board assemblies (PCBAs) include an RF transmitting node. The PCBAs(s) are spaced apart from one another within the cavity. An RF shield guide layer is positioned between the PCBAs and the cover, such that the RF shield guide layer covers the PCBAs without covering the RF transmitting node. A battery pack and an electric powertrain system include the RF shield guide layer.
    Type: Application
    Filed: December 10, 2021
    Publication date: June 15, 2023
    Applicant: GM GLOBAL TECHNOLOGY OPERATIONS LLC
    Inventors: Fiona E. Meyer-Teruel, Aseim M. Elfrgani, Christopher A. O'Brien, Sony Mathews, Hatem Elgothamy
  • Publication number: 20150361180
    Abstract: The invention relates to a method of testing a compound for biological activity, which method comprises providing cells expressing one of the CD94/NKG2 family of receptors, contacting the cells with recombinant HLA-E under binding conditions in the presence of the test compound, and determining whether the presence of the compound affects the binding of HLA-E to the cells. The HLA-E property of binding to CD94/NKG2 receptors on NK cells and a subset of CD8+ T cells is useful for targeting CD94/NKG2+ cells for a variety of purposes such as identification, isolation, killing or inactivation.
    Type: Application
    Filed: April 10, 2015
    Publication date: December 17, 2015
    Applicant: ISIS INNOVATION LIMITED
    Inventors: Veronique M. Braud, David S.J. Allan, Graham S. Ogg, Christopher A. O'Callaghan, Andrew J. McMichael
  • Publication number: 20080274475
    Abstract: The invention relates to a method of testing a compound for biological activity, which method comprises providing cells expressing one of the CD94/NKG2 family of receptors, contacting the cells with recombinant HLA-E under binding conditions in the presence of the test compound, and determining whether the presence of the compound affects the binding of HLA-E to the cells. The HLA-E property of binding to CD94/NKG2 receptors on NK cells and a subset of CD8+ T cells is useful for targeting CD94/NKG2+ cells for a variety of purposes such as identification, isolation, killing or inactivation.
    Type: Application
    Filed: April 25, 2008
    Publication date: November 6, 2008
    Applicant: ISIS INNOVATION LIMITED
    Inventors: Veronique M. Braud, David S.J. Allan, Graham S. Ogg, Christopher A. O'Callaghan, Andrew J. McMichael
  • Patent number: 7410767
    Abstract: The invention relates to a method of testing a compound for biological activity, which method comprises providing cells expressing one of the CD94/NKG2 family of receptors, contacting the cells with recombinant HLA-E under binding conditions in the presence of the test compound, and determining whether the presence of the compound affects the binding of HLA-E to the cells. The HLA-E property of binding to CD94/NKG2 receptors on NK cells and a subset of CD8+ T cells is useful for targeting CD94/NKG2+ cells for a variety of purposes such as identification, isolation, killing or inactivation.
    Type: Grant
    Filed: December 4, 1998
    Date of Patent: August 12, 2008
    Assignee: Isis Innovation Limited
    Inventors: Veronique M. Braud, David S. J. Allan, Graham S. Ogg, Christopher A. O'Callaghan, Andrew J. McMichael
  • Patent number: 6491371
    Abstract: An improved ink blotter method system usable in a maintenance station of an ink jet printer including wiper blades positioned to clean the printheads and an assembly of absorbent materials to clean the wiper blades.
    Type: Grant
    Filed: June 16, 2000
    Date of Patent: December 10, 2002
    Assignee: Xerox Corporation
    Inventors: Richard H. Berg, Christopher A. O'Dell, Steven J. Dietl